{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "mount_file_id": "1McVAdpwCFSgkZMklSlm9MUxXqrMDMet6",
      "authorship_tag": "ABX9TyP5bHC0MynXz5/fVjJTgM9U",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/utkarshbelkhede/Financial_Dashboard/blob/master/notebooks/3_Combining_Dataset.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "1OVYUI_A-r8N"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "import numpy as np"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Working Directory\n",
        "import os\n",
        "os.chdir('/content/drive/MyDrive/Documents/Market Intelligence')"
      ],
      "metadata": {
        "id": "3nGRUX-fB64b"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df = pd.read_csv('./datasets/raw/abbvie.csv')\n",
        "df = df.iloc[:,1:]\n",
        "df.head(1)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 212
        },
        "id": "ZIhxL4Ds_R8t",
        "outputId": "d62dd528-2150-4b96-c27b-1093be7e2d11"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "  Company Reporting_Date                                                  1  \\\n",
              "0    abbv       20211231   ITEM 1. BUSINESS Overview AbbVie (1) is a glo...   \n",
              "\n",
              "                                                  1A  \\\n",
              "0   ITEM 1A. RISK FACTORS You should carefully co...   \n",
              "\n",
              "                                           1B  \\\n",
              "0   ITEM 1B. UNRESOLVED STAFF COMMENTS None.    \n",
              "\n",
              "                                                   2  \\\n",
              "0   ITEM 2. PROPERTIES AbbVie's corporate offices...   \n",
              "\n",
              "                                                   3  \\\n",
              "0   ITEM 3. LEGAL PROCEEDINGS Information pertain...   \n",
              "\n",
              "                                                   5  \\\n",
              "0   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "\n",
              "                                                   7  \\\n",
              "0   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "\n",
              "                                                  7A  \\\n",
              "0   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "\n",
              "                                                   8  \\\n",
              "0   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "\n",
              "                                                  9A  \n",
              "0   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-d04e023c-116e-44ae-90cc-1107e17972a8\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Company</th>\n",
              "      <th>Reporting_Date</th>\n",
              "      <th>1</th>\n",
              "      <th>1A</th>\n",
              "      <th>1B</th>\n",
              "      <th>2</th>\n",
              "      <th>3</th>\n",
              "      <th>5</th>\n",
              "      <th>7</th>\n",
              "      <th>7A</th>\n",
              "      <th>8</th>\n",
              "      <th>9A</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>abbv</td>\n",
              "      <td>20211231</td>\n",
              "      <td>ITEM 1. BUSINESS Overview AbbVie (1) is a glo...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS You should carefully co...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS None.</td>\n",
              "      <td>ITEM 2. PROPERTIES AbbVie's corporate offices...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Information pertain...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-d04e023c-116e-44ae-90cc-1107e17972a8')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-d04e023c-116e-44ae-90cc-1107e17972a8 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-d04e023c-116e-44ae-90cc-1107e17972a8');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 3
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "columns = list(df.columns)"
      ],
      "metadata": {
        "id": "BWhLotnQGdbp"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "year_list = ['2021','2020','2019','2018','2017']"
      ],
      "metadata": {
        "id": "lp1guc2gG-hf"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def change_name_year(df, name, year_list, columns):\n",
        "  arr = df.to_numpy()\n",
        "\n",
        "  for row in range(len(arr)):\n",
        "    for col in range(len(arr[0])):\n",
        "      if col == 0:\n",
        "        arr[row][col] = name\n",
        "      if col == 1:\n",
        "        arr[row][col] = year_list[row]     \n",
        "\n",
        "  return pd.DataFrame(arr, columns = columns)\n",
        "\n",
        "change_name_year(df, \"AbbVie\", year_list, columns)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 649
        },
        "id": "Ef_c5paIFRp_",
        "outputId": "b4ea7916-3b53-44db-bb13-3f48054e6ff8"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "  Company Reporting_Date                                                  1  \\\n",
              "0  AbbVie           2021   ITEM 1. BUSINESS Overview AbbVie (1) is a glo...   \n",
              "1  AbbVie           2020   ITEM 1. BUSINESS Overview AbbVie (1) is a glo...   \n",
              "2  AbbVie           2019   ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...   \n",
              "3  AbbVie           2018   ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...   \n",
              "4  AbbVie           2017   ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...   \n",
              "\n",
              "                                                  1A  \\\n",
              "0   ITEM 1A. RISK FACTORS You should carefully co...   \n",
              "1   ITEM 1A. RISK FACTORS You should carefully co...   \n",
              "2   ITEM 1A. RISK FACTORS  You should carefully c...   \n",
              "3   ITEM 1A. RISK FACTORS   You should carefully ...   \n",
              "4   ITEM 1A. RISK FACTORS   You should carefully ...   \n",
              "\n",
              "                                            1B  \\\n",
              "0    ITEM 1B. UNRESOLVED STAFF COMMENTS None.    \n",
              "1    ITEM 1B. UNRESOLVED STAFF COMMENTS None.    \n",
              "2   ITEM 1B. UNRESOLVED STAFF COMMENTS  None.    \n",
              "3   ITEM 1B. UNRESOLVED STAFF COMMENTS  None.    \n",
              "4   ITEM 1B. UNRESOLVED STAFF COMMENTS  None.    \n",
              "\n",
              "                                                   2  \\\n",
              "0   ITEM 2. PROPERTIES AbbVie's corporate offices...   \n",
              "1   ITEM 2. PROPERTIES AbbVie's corporate offices...   \n",
              "2   ITEM 2. PROPERTIES  AbbVie's corporate office...   \n",
              "3   ITEM 2. PROPERTIES  AbbVie's corporate office...   \n",
              "4   ITEM 2. PROPERTIES  AbbVie's corporate office...   \n",
              "\n",
              "                                                   3  \\\n",
              "0   ITEM 3. LEGAL PROCEEDINGS Information pertain...   \n",
              "1   ITEM 3. LEGAL PROCEEDINGS Information pertain...   \n",
              "2   ITEM 3. LEGAL PROCEEDINGS  Information pertai...   \n",
              "3   ITEM 3. LEGAL PROCEEDINGS  Information pertai...   \n",
              "4   ITEM 3. LEGAL PROCEEDINGS  Information pertai...   \n",
              "\n",
              "                                                   5  \\\n",
              "0   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "1   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "2   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "3   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "4   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "\n",
              "                                                   7  \\\n",
              "0   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "1   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "2   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "3   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "4   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "\n",
              "                                                  7A  \\\n",
              "0   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "1   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "2   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "3   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "4   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "\n",
              "                                                   8  \\\n",
              "0   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "1   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "2   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "3   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "4   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "\n",
              "                                                  9A  \n",
              "0   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "1   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "2   ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...  \n",
              "3   ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...  \n",
              "4   ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-41811610-7f03-48f7-9bce-1bbc4ce3ba39\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Company</th>\n",
              "      <th>Reporting_Date</th>\n",
              "      <th>1</th>\n",
              "      <th>1A</th>\n",
              "      <th>1B</th>\n",
              "      <th>2</th>\n",
              "      <th>3</th>\n",
              "      <th>5</th>\n",
              "      <th>7</th>\n",
              "      <th>7A</th>\n",
              "      <th>8</th>\n",
              "      <th>9A</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESS Overview AbbVie (1) is a glo...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS You should carefully co...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS None.</td>\n",
              "      <td>ITEM 2. PROPERTIES AbbVie's corporate offices...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Information pertain...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESS Overview AbbVie (1) is a glo...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS You should carefully co...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS None.</td>\n",
              "      <td>ITEM 2. PROPERTIES AbbVie's corporate offices...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Information pertain...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2019</td>\n",
              "      <td>ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS  You should carefully c...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS  None.</td>\n",
              "      <td>ITEM 2. PROPERTIES  AbbVie's corporate office...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS  Information pertai...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS   You should carefully ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS  None.</td>\n",
              "      <td>ITEM 2. PROPERTIES  AbbVie's corporate office...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS  Information pertai...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2017</td>\n",
              "      <td>ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS   You should carefully ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS  None.</td>\n",
              "      <td>ITEM 2. PROPERTIES  AbbVie's corporate office...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS  Information pertai...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-41811610-7f03-48f7-9bce-1bbc4ce3ba39')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-41811610-7f03-48f7-9bce-1bbc4ce3ba39 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-41811610-7f03-48f7-9bce-1bbc4ce3ba39');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 6
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "raw_data_files = os.listdir('./datasets/raw/')\n",
        "raw_data_files"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bKYw6snH4o0s",
        "outputId": "f1c82066-169e-478b-cff9-4677c00c6b8c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "['meta.csv',\n",
              " 'merck.csv',\n",
              " 'alphabet.csv',\n",
              " 'microsoft.csv',\n",
              " 'costco.csv',\n",
              " 'pfizer.csv',\n",
              " 'pepsico.csv',\n",
              " 'abbvie.csv',\n",
              " 'coca-cola.csv',\n",
              " 'mastercard.csv']"
            ]
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "company_names_list = [\n",
        "    \"Meta\", \n",
        "    \"Merck & Co.\", \n",
        "    \"Alphabet Inc.\", \n",
        "    \"Microsoft Corporation\", \n",
        "    \"Costco\",\n",
        "    \"Pfizer\",\n",
        "    \"PepsiCo\",\n",
        "    \"AbbVie\",\n",
        "    \"Coca-Cola\",\n",
        "    \"Mastercard\"\n",
        "    ]"
      ],
      "metadata": {
        "id": "xgVO9ZGK6LSJ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "PATH = './datasets/raw/'"
      ],
      "metadata": {
        "id": "8yeSRs988r4C"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Returns combined dataset\n",
        "def combine_dataset(PATH, raw_data_files, company_names_list, year_list):\n",
        "  for i, (file, company) in enumerate(zip(raw_data_files, company_names_list)):\n",
        "    df = pd.read_csv(PATH + file)\n",
        "    df = df.iloc[:,1:]\n",
        "    # Setting up appropriate names and year\n",
        "    df = change_name_year(df, company, year_list, columns)\n",
        "\n",
        "    # Skipping concatenation in the first iteration\n",
        "    if i == 0:\n",
        "      arr = df.to_numpy()\n",
        "    else:\n",
        "      arr1 = df.to_numpy()\n",
        "      arr = np.concatenate((arr, arr1), axis = 0)\n",
        "\n",
        "  return pd.DataFrame(arr, columns = columns)"
      ],
      "metadata": {
        "id": "yv8PxMQB8NZG"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "final_combined_dataset = combine_dataset(PATH, raw_data_files, company_names_list, year_list)\n",
        "final_combined_dataset"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "-mIK2QoLE6Hf",
        "outputId": "2b65bf7d-9365-4c5c-b9de-92037892f685"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                  Company Reporting_Date  \\\n",
              "0                    Meta           2021   \n",
              "1                    Meta           2020   \n",
              "2                    Meta           2019   \n",
              "3                    Meta           2018   \n",
              "4                    Meta           2017   \n",
              "5             Merck & Co.           2021   \n",
              "6             Merck & Co.           2020   \n",
              "7             Merck & Co.           2019   \n",
              "8             Merck & Co.           2018   \n",
              "9             Merck & Co.           2017   \n",
              "10          Alphabet Inc.           2021   \n",
              "11          Alphabet Inc.           2020   \n",
              "12          Alphabet Inc.           2019   \n",
              "13          Alphabet Inc.           2018   \n",
              "14  Microsoft Corporation           2021   \n",
              "15  Microsoft Corporation           2020   \n",
              "16  Microsoft Corporation           2019   \n",
              "17  Microsoft Corporation           2018   \n",
              "18  Microsoft Corporation           2017   \n",
              "19                 Costco           2021   \n",
              "20                 Costco           2020   \n",
              "21                 Costco           2019   \n",
              "22                 Costco           2018   \n",
              "23                 Costco           2017   \n",
              "24                 Pfizer           2021   \n",
              "25                 Pfizer           2020   \n",
              "26                 Pfizer           2019   \n",
              "27                 Pfizer           2018   \n",
              "28                 Pfizer           2017   \n",
              "29                PepsiCo           2021   \n",
              "30                PepsiCo           2020   \n",
              "31                PepsiCo           2019   \n",
              "32                PepsiCo           2018   \n",
              "33                PepsiCo           2017   \n",
              "34                 AbbVie           2021   \n",
              "35                 AbbVie           2020   \n",
              "36                 AbbVie           2019   \n",
              "37                 AbbVie           2018   \n",
              "38                 AbbVie           2017   \n",
              "39              Coca-Cola           2021   \n",
              "40              Coca-Cola           2020   \n",
              "41              Coca-Cola           2019   \n",
              "42              Coca-Cola           2018   \n",
              "43              Coca-Cola           2017   \n",
              "44             Mastercard           2021   \n",
              "45             Mastercard           2020   \n",
              "46             Mastercard           2019   \n",
              "47             Mastercard           2018   \n",
              "48             Mastercard           2017   \n",
              "\n",
              "                                                    1  \\\n",
              "0    Item 1. Business Overview Our mission is to g...   \n",
              "1    Item 1. Business Overview Our mission is to g...   \n",
              "2    Item 1. Business Overview Our mission is to g...   \n",
              "3    Item 1. Business Overview Our mission is to g...   \n",
              "4    Item 1. Business Overview Our mission is to g...   \n",
              "5    Item 1. Business. Merck  Co., Inc. (Merck or ...   \n",
              "6    Item 1. Business. Merck  Co., Inc. (Merck or ...   \n",
              "7    Item 1. Business. Merck  Co., Inc. (Merck or ...   \n",
              "8    Item 1. Business. Merck  Co., Inc. (Merck or ...   \n",
              "9    Item 1. Business. Merck  Co., Inc. (Merck or ...   \n",
              "10   ITEM 1. BUSINESS Overview As our founders Lar...   \n",
              "11   ITEM 1. BUSINESS Overview As our founders Lar...   \n",
              "12   ITEM 1. BUSINESS Overview As our founders Lar...   \n",
              "13   ITEM 1. BUSINESS Overview As our founders Lar...   \n",
              "14   ITEM 1. BUSINESSGENERAL Embracing Our FutureM...   \n",
              "15   ITEM 1. BUSINESSGENERAL Embracing Our FutureM...   \n",
              "16   ITEM 1. BUSINESS GENERAL Embracing Our Future...   \n",
              "17   ITEM 1. BUSINESS GENERAL Embracing Our Future...   \n",
              "18   ITEM 1. BUSINESS GENERAL Embracing Our Future...   \n",
              "19   Item 1Business Costco Wholesale Corporation a...   \n",
              "20   Item 1Business Costco Wholesale Corporation a...   \n",
              "21   Item 1Business Costco Wholesale Corporation a...   \n",
              "22   Item 1Business Costco Wholesale Corporation a...   \n",
              "23   Item 1Business Costco Wholesale Corporation a...   \n",
              "24   ITEM 1. BUSINESS ABOUT PFIZER Pfizer Inc. is ...   \n",
              "25   ITEM 1. BUSINESS ABOUT PFIZER Pfizer Inc. is ...   \n",
              "26   Item 1. BusinessAbout Pfizer section in this ...   \n",
              "27   ITEM 1. BUSINESS ABOUT PFIZER Pfizer Inc. is ...   \n",
              "28   ITEM 1. BUSINESS GENERAL Pfizer Inc. is a res...   \n",
              "29   Item 1. Business. When used in this report, t...   \n",
              "30   Item 1. Business. When used in this report, t...   \n",
              "31   Item 1. Business. When used in this report, t...   \n",
              "32   Item 1. Business. When used in this report, t...   \n",
              "33   Item 1. Business. When used in this report, t...   \n",
              "34   ITEM 1. BUSINESS Overview AbbVie (1) is a glo...   \n",
              "35   ITEM 1. BUSINESS Overview AbbVie (1) is a glo...   \n",
              "36   ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...   \n",
              "37   ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...   \n",
              "38   ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...   \n",
              "39   ITEM 1. BUSINESS In this report, the terms Th...   \n",
              "40   ITEM 1. BUSINESS In this report, the terms \"T...   \n",
              "41   ITEM 1. BUSINESS In this report, the terms \"T...   \n",
              "42   ITEM 1. BUSINESS In this report, the terms \"T...   \n",
              "43   ITEM 1. BUSINESS In this report, the terms \"T...   \n",
              "44   ITEM 1. BUSINESS Item 1. Business Overview Ma...   \n",
              "45   ITEM 1. BUSINESS Item 1. Business Overview Ma...   \n",
              "46                             Item 1. Business         \n",
              "47   ITEM 1.  BUSINESS Overview Mastercard is a te...   \n",
              "48   ITEM 1.  BUSINESS Overview Mastercard is a te...   \n",
              "\n",
              "                                                   1A  \\\n",
              "0    Item 1A. Risk Factors Certain factors may hav...   \n",
              "1    Item 1A. Risk Factors Certain factors may hav...   \n",
              "2    Item 1A. Risk Factors Certain factors may hav...   \n",
              "3    Item 1A. Risk Factors Certain factors may hav...   \n",
              "4    Item 1A. Risk Factors Certain factors may hav...   \n",
              "5    Item 1A. Risk Factors. Summary Risk Factors T...   \n",
              "6    Item 1A. Risk Factors. Summary Risk Factors T...   \n",
              "7    Item 1A. Risk Factors. Investors should caref...   \n",
              "8    Item 1A. Risk Factors. Investors should caref...   \n",
              "9    Item 1A. Risk Factors. Investors should caref...   \n",
              "10   ITEM 1A. RISK FACTORS Our operations and fina...   \n",
              "11   ITEM 1A. RISK FACTORS Our operations and fina...   \n",
              "12   ITEM 1A. RISK FACTORS Our operations and fina...   \n",
              "13   ITEM 1A. RISK FACTORS Our operations and fina...   \n",
              "14   ITEM 1A. RISK FACTORSOur operations and finan...   \n",
              "15   ITEM 1A. RISK FACTORS Our operations and fina...   \n",
              "16   ITEM 1A. RISK FACTORS Our operations and fina...   \n",
              "17   ITEM 1A. RIS K FACTORS Our operations and fin...   \n",
              "18   ITEM 1A. RIS K FACTORS Our operations and fin...   \n",
              "19   Item 1ARisk Factors The risks described below...   \n",
              "20   Item 1ARisk Factors The risks described below...   \n",
              "21   Item 1ARisk Factors The risks described below...   \n",
              "22   Item 1ARisk Factors The risks described below...   \n",
              "23   Item 1ARisk Factors The risks described below...   \n",
              "24   ITEM 1A. RISK FACTORS This section describes ...   \n",
              "25   ITEM 1A. RISK FACTORS This section describes ...   \n",
              "26   ITEM 1A. RISK FACTORS The statements in this ...   \n",
              "27   ITEM 1A. RISK FACTORS The statements in this ...   \n",
              "28   ITEM 1A. RISK FACTORS The statements in this ...   \n",
              "29   Item 1A. Risk Factors. The following risks, s...   \n",
              "30   Item 1A. Risk Factors. The following risks, s...   \n",
              "31   Item 1A. Risk Factors. You should carefully c...   \n",
              "32   Item 1A. Risk Factors. You should carefully c...   \n",
              "33   Item 1A. Risk Factors. You should carefully c...   \n",
              "34   ITEM 1A. RISK FACTORS You should carefully co...   \n",
              "35   ITEM 1A. RISK FACTORS You should carefully co...   \n",
              "36   ITEM 1A. RISK FACTORS  You should carefully c...   \n",
              "37   ITEM 1A. RISK FACTORS   You should carefully ...   \n",
              "38   ITEM 1A. RISK FACTORS   You should carefully ...   \n",
              "39   ITEM 1A. RISK FACTORS In addition to the othe...   \n",
              "40   ITEM 1A. RISK FACTORS In addition to the othe...   \n",
              "41   ITEM 1A. RISK FACTORS In addition to the othe...   \n",
              "42   ITEM 1A. RISK FACTORS In addition to the othe...   \n",
              "43   ITEM 1A. RISK FACTORS In addition to the othe...   \n",
              "44   Item 1A. Risk factors RISK HIGHLIGHTS Legal a...   \n",
              "45   ITEM 1A. RISK FACTORS Item 1A. Risk factors R...   \n",
              "46                        Item 1A. Risk factors         \n",
              "47   ITEM 1A. RISK FACTORS Legal and Regulatory Pa...   \n",
              "48   ITEM 1A. RISK FACTORS Legal and Regulatory Di...   \n",
              "\n",
              "                                                   1B  \\\n",
              "0           Item 1B. Unresolved Staff Comments None.    \n",
              "1           Item 1B. Unresolved Staff Comments None.    \n",
              "2           Item 1B. Unresolved Staff Comments None.    \n",
              "3           Item 1B. Unresolved Staff Comments None.    \n",
              "4           Item 1B. Unresolved Staff Comments None.    \n",
              "5          Item 1B. Unresolved Staff Comments. None.    \n",
              "6          Item 1B. Unresolved Staff Comments. None.    \n",
              "7          Item 1B. Unresolved Staff Comments. None.    \n",
              "8          Item 1B. Unresolved Staff Comments. None.    \n",
              "9          Item 1B. Unresolved Staff Comments. None.    \n",
              "10   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "11   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "12   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "13   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "14   ITEM 1B. UNRESOLVED STAFF COMMENTS We have re...   \n",
              "15   ITEM 1B. UNRESOLVED STAFF COMMENTS We have re...   \n",
              "16   ITEM 1B. UNRESOLVED STAFF COMMENTS We have re...   \n",
              "17   ITEM 1B. UNRESOLVE D STAFF COMMENTS We have r...   \n",
              "18   ITEM 1B. UNRESOLVE D STAFF COMMENTS We have r...   \n",
              "19            Item 1BUnresolved Staff Comments None.    \n",
              "20            Item 1BUnresolved Staff Comments None.    \n",
              "21            Item 1BUnresolved Staff Comments None.    \n",
              "22            Item 1BUnresolved Staff Comments None.    \n",
              "23            Item 1BUnresolved Staff Comments None.    \n",
              "24   ITEM 1B. UNRESOLVED STAFF COMMENTS N/A ITEM 2...   \n",
              "25   ITEM 1B. UNRESOLVED STAFF COMMENTS N/A ITEM 2...   \n",
              "26   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "27   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "28   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "29   Item 1B. Unresolved Staff Comments. We have r...   \n",
              "30   Item 1B. Unresolved Staff Comments. We have r...   \n",
              "31   Item 1B. Unresolved Staff Comments. We have r...   \n",
              "32   Item 1B. Unresolved Staff Comments. We have r...   \n",
              "33   Item 1B. Unresolved Staff Comments. We have r...   \n",
              "34          ITEM 1B. UNRESOLVED STAFF COMMENTS None.    \n",
              "35          ITEM 1B. UNRESOLVED STAFF COMMENTS None.    \n",
              "36         ITEM 1B. UNRESOLVED STAFF COMMENTS  None.    \n",
              "37         ITEM 1B. UNRESOLVED STAFF COMMENTS  None.    \n",
              "38         ITEM 1B. UNRESOLVED STAFF COMMENTS  None.    \n",
              "39   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "40   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "41   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "42   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "43   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "44   Item 1B. Unresolved staff comments Not applic...   \n",
              "45   Item 1B. Unresolved staff comments Not applic...   \n",
              "46           Item 1B. Unresolved staff comments         \n",
              "47   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "48   ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...   \n",
              "\n",
              "                                                    2  \\\n",
              "0    Item 2. Properties Our corporate headquarters...   \n",
              "1    Item 2. Properties  Our corporate headquarter...   \n",
              "2    Item 2. Properties  Our corporate headquarter...   \n",
              "3    Item 2. Properties  Our corporate headquarter...   \n",
              "4    Item 2. Properties  Our corporate headquarter...   \n",
              "5    Item 2. Properties. The Companys corporate he...   \n",
              "6    Item 2. Properties. The Companys corporate he...   \n",
              "7    Item 2. Properties. The Companys corporate he...   \n",
              "8    Item 2. Properties. The Companys corporate he...   \n",
              "9    Item 2. Properties. The Companys corporate he...   \n",
              "10   ITEM 2. PROPERTIES Our headquarters are locat...   \n",
              "11   ITEM 2. PROPERTIES Our headquarters are locat...   \n",
              "12   ITEM 2. PROPERTIES Our headquarters are locat...   \n",
              "13   ITEM 2. PROPERTIES Our headquarters are locat...   \n",
              "14   ITEM 2. PROPERTIES Our corporate headquarters...   \n",
              "15   ITEM 2. PROPERTIES Our corporate headquarters...   \n",
              "16   ITEM 2. PROPERTIES Our corporate headquarters...   \n",
              "17   ITEM 2. PROPERTIES Our corporate headquarters...   \n",
              "18   ITEM 2. PROPERTIES Our corporate headquarters...   \n",
              "19   Item 2Properties Warehouse Properties At Augu...   \n",
              "20   Item 2Properties Warehouse Properties At Augu...   \n",
              "21   Item 2Properties Warehouse Properties At Sept...   \n",
              "22   Item 2Properties Warehouse Properties At Sept...   \n",
              "23   Item 2Properties Warehouse Properties At Sept...   \n",
              "24   ITEM 2. PROPERTIES We own and lease space glo...   \n",
              "25   ITEM 2. PROPERTIES We own and lease space aro...   \n",
              "26   ITEM 2. PROPERTIES As of December 31, 2019 , ...   \n",
              "27   ITEM 2. PROPERTIES In 2017 , we continued to ...   \n",
              "28   ITEM 2. PROPERTIES In 2016, we continued to c...   \n",
              "29   Item 2. Properties. Our principal executive o...   \n",
              "30   Item 2. Properties. Our principal executive o...   \n",
              "31   Item 2. Properties. Our principal executive o...   \n",
              "32   Item 2. Properties. Our principal executive o...   \n",
              "33   Item 2. Properties. Our principal executive o...   \n",
              "34   ITEM 2. PROPERTIES AbbVie's corporate offices...   \n",
              "35   ITEM 2. PROPERTIES AbbVie's corporate offices...   \n",
              "36   ITEM 2. PROPERTIES  AbbVie's corporate office...   \n",
              "37   ITEM 2. PROPERTIES  AbbVie's corporate office...   \n",
              "38   ITEM 2. PROPERTIES  AbbVie's corporate office...   \n",
              "39   ITEM 2. PROPERTIES Our worldwide headquarters...   \n",
              "40   ITEM 2. PROPERTIES Our worldwide headquarters...   \n",
              "41   ITEM 2. PROPERTIES Our worldwide headquarters...   \n",
              "42   ITEM 2. PROPERTIES Our worldwide headquarters...   \n",
              "43   ITEM 2. PROPERTIES Our worldwide headquarters...   \n",
              "44   Item 2. Properties We own our corporate headq...   \n",
              "45   Item 2. Properties We own our corporate headq...   \n",
              "46                           Item 2. Properties         \n",
              "47   ITEM 2. PROPERTIES As of December 31, 2018 , ...   \n",
              "48   ITEM 2. PROPERTIES As of December 31, 2017 , ...   \n",
              "\n",
              "                                                    3  \\\n",
              "0    Item 3. Legal Proceedings Beginning on March ...   \n",
              "1    Item 3. Legal Proceedings Beginning on March ...   \n",
              "2    Item 3. Legal Proceedings Beginning on March ...   \n",
              "3    Item 3. Legal Proceedings Beginning on March ...   \n",
              "4    Item 3. Legal Proceedings Beginning on May 22...   \n",
              "5    Item 3. Legal Proceedings. The information ca...   \n",
              "6    Item 3. Legal Proceedings. The information ca...   \n",
              "7    Item 3. Legal Proceedings. The information ca...   \n",
              "8    Item 3. Legal Proceedings. The information ca...   \n",
              "9    Item 3. Legal Proceedings. The information ca...   \n",
              "10   ITEM 3. LEGAL PROCEEDINGS For a description o...   \n",
              "11   ITEM 3. LEGAL PROCEEDINGS For a description o...   \n",
              "12   ITEM 3. LEGAL PROCEEDINGS For a description o...   \n",
              "13   ITEM 3. LEGAL PROCEEDINGS For a description o...   \n",
              "14   ITEM 3. LEGAL PROCEEDINGS Refer to Note 15  C...   \n",
              "15   ITEM 3. LEGAL PROCEEDINGS While not material ...   \n",
              "16   ITEM 3. LEGAL PROCEEDINGS While not material ...   \n",
              "17   ITEM 3. LEGAL PROCEEDINGS While not material ...   \n",
              "18   ITEM 3. LEGAL PROCEEDINGS While not material ...   \n",
              "19   Item 3Legal Proceedings See discussion of Leg...   \n",
              "20   Item 3Legal Proceedings See discussion of Leg...   \n",
              "21   Item 3Legal Proceedings See discussion of Leg...   \n",
              "22   Item 3Legal Proceedings See discussion of Leg...   \n",
              "23   Item 3Legal Proceedings See discussion of Leg...   \n",
              "24   ITEM 3. LEGAL PROCEEDINGS Certain legal proce...   \n",
              "25   ITEM 3. LEGAL PROCEEDINGS Certain legal proce...   \n",
              "26   ITEM 3. LEGAL PROCEEDINGS Certain legal proce...   \n",
              "27   ITEM 3. LEGAL PROCEEDINGS Certain legal proce...   \n",
              "28   ITEM 3. LEGAL PROCEEDINGS Certain legal proce...   \n",
              "29   Item 3. Legal Proceedings. We and our subsidi...   \n",
              "30   Item 3. Legal Proceedings. We and our subsidi...   \n",
              "31   Item 3. Legal Proceedings. We and our subsidi...   \n",
              "32   Item 3. Legal Proceedings. As previously disc...   \n",
              "33   Item 3. Legal Proceedings. As previously disc...   \n",
              "34   ITEM 3. LEGAL PROCEEDINGS Information pertain...   \n",
              "35   ITEM 3. LEGAL PROCEEDINGS Information pertain...   \n",
              "36   ITEM 3. LEGAL PROCEEDINGS  Information pertai...   \n",
              "37   ITEM 3. LEGAL PROCEEDINGS  Information pertai...   \n",
              "38   ITEM 3. LEGAL PROCEEDINGS  Information pertai...   \n",
              "39   ITEM 3. LEGAL PROCEEDINGS The Company is invo...   \n",
              "40   ITEM 3. LEGAL PROCEEDINGS The Company is invo...   \n",
              "41   ITEM 3. LEGAL PROCEEDINGS The Company is invo...   \n",
              "42   ITEM 3. LEGAL PROCEEDINGS The Company is invo...   \n",
              "43   ITEM 3. LEGAL PROCEEDINGS The Company is invo...   \n",
              "44   Item 3. Legal proceedings Refer to Note 13 (A...   \n",
              "45   Item 3. Legal proceedings Refer to Note 13 (A...   \n",
              "46                    Item 3. Legal proceedings         \n",
              "47   ITEM 3. LEGAL PROCEEDINGS Refer to Note 12 (A...   \n",
              "48   ITEM 3. LEGAL PROCEEDINGS Refer to Notes 10 (...   \n",
              "\n",
              "                                                    5  \\\n",
              "0    Item 5. Market for Registrant's Common Equity...   \n",
              "1    Item 5. Market for Registrant's Common Equity...   \n",
              "2    Item 5. Market for Registrant's Common Equity...   \n",
              "3    Item 5. Market for Registrant's Common Equity...   \n",
              "4    Item 5. Market for Registrant's Common Equity...   \n",
              "5    Item 5. Market for Registrants Common Equity,...   \n",
              "6    Item 5. Market for Registrants Common Equity,...   \n",
              "7    Item 5. Market for Registrants Common Equity,...   \n",
              "8    Item 5. Market for Registrants Common Equity,...   \n",
              "9    Item 5. Market for Registrants Common Equity,...   \n",
              "10   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "11   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "12   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "13   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "14   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "15   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "16   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "17   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "18   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "19   Item 5Market for Registrants Common Equity, R...   \n",
              "20   Item 5Market for Registrants Common Equity, R...   \n",
              "21   Item 5Market for Registrants Common Equity, R...   \n",
              "22   Item 5Market for Registrants Common Equity, R...   \n",
              "23   Item 5Market for Registrants Common Equity, R...   \n",
              "24   ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...   \n",
              "25   ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...   \n",
              "26   ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...   \n",
              "27   ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...   \n",
              "28   ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...   \n",
              "29   Item 5. Market for Registrants Common Equity,...   \n",
              "30   Item 5. Market for Registrants Common Equity,...   \n",
              "31   Item 5. Market for Registrants Common Equity,...   \n",
              "32   Item 5. Market for Registrants Common Equity,...   \n",
              "33   Item 5. Market for Registrants Common Equity,...   \n",
              "34   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "35   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "36   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "37   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "38   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "39   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "40   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "41   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "42   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "43   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "44   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "45   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "46   ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...   \n",
              "47   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "48   ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...   \n",
              "\n",
              "                                                    7  \\\n",
              "0    Item 7. Management's Discussion and Analysis ...   \n",
              "1    Item 7. Management's Discussion and Analysis ...   \n",
              "2    Item 7. Management's Discussion and Analysis ...   \n",
              "3    Item 7. Management's Discussion and Analysis ...   \n",
              "4    Item 7. Management's Discussion and Analysis ...   \n",
              "5    Item 7. Managements Discussion and Analysis o...   \n",
              "6    Item 7. Managements Discussion and Analysis o...   \n",
              "7    Item 7. Managements Discussion and Analysis o...   \n",
              "8    Item 7. Managements Discussion and Analysis o...   \n",
              "9    Item 7. Managements Discussion and Analysis o...   \n",
              "10   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "11   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "12   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "13   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "14   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "15   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "16   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "17   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "18   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "19   Item 7Management's Discussion and Analysis of...   \n",
              "20   Item 7Management's Discussion and Analysis of...   \n",
              "21   Item 7Management's Discussion and Analysis of...   \n",
              "22   Item 7Management's Discussion and Analysis of...   \n",
              "23   Item 7Managements Discussion and Analysis of ...   \n",
              "24   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "25   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "26   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "27   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "28   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "29   Item 7. Managements Discussion and Analysis o...   \n",
              "30   Item 7. Managements Discussion and Analysis o...   \n",
              "31   Item 7. Managements Discussion and Analysis o...   \n",
              "32   Item 7. Managements Discussion and Analysis o...   \n",
              "33   Item 7. Managements Discussion and Analysis o...   \n",
              "34   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "35   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "36   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "37   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "38   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "39   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "40   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "41   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "42   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "43   ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...   \n",
              "44   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "45   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "46   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "47   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "48   ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...   \n",
              "\n",
              "                                                   7A  \\\n",
              "0    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "1    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "2    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "3    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "4    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "5    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "6    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "7    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "8    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "9    Item 7A. Quantitative and Qualitative Disclos...   \n",
              "10   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "11   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "12   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "13   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "14   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "15   ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...   \n",
              "16   ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...   \n",
              "17   ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...   \n",
              "18   ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...   \n",
              "19   Item 7AQuantitative and Qualitative Disclosur...   \n",
              "20   Item 7AQuantitative and Qualitative Disclosur...   \n",
              "21   Item 7AQuantitative and Qualitative Disclosur...   \n",
              "22   Item 7AQuantitative and Qualitative Disclosur...   \n",
              "23   Item 7AQuantitative and Qualitative Disclosur...   \n",
              "24   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "25   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "26   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "27   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "28   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "29   Item 7A. Quantitative and Qualitative Disclos...   \n",
              "30   Item 7A. Quantitative and Qualitative Disclos...   \n",
              "31   Item 7A. Quantitative and Qualitative Disclos...   \n",
              "32   Item 7A. Quantitative and Qualitative Disclos...   \n",
              "33   Item 7A. Quantitative and Qualitative Disclos...   \n",
              "34   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "35   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "36   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "37   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "38   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "39   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "40   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "41   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "42   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "43   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "44   ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...   \n",
              "45   Item 7A. Quantitative and qualitative disclos...   \n",
              "46   Item 7A. Quantitative and qualitative disclos...   \n",
              "47   ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLO...   \n",
              "48   ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLO...   \n",
              "\n",
              "                                                    8  \\\n",
              "0    Item 8. Financial Statements and Supplementar...   \n",
              "1    Item 8. Financial Statements and Supplementar...   \n",
              "2    Item 8. Financial Statements and Supplementar...   \n",
              "3    Item 8. Financial Statements and Supplementar...   \n",
              "4    Item 8. Financial Statements and Supplementar...   \n",
              "5    Item 8. Financial Statements and Supplementar...   \n",
              "6    Item 8. Financial Statements and Supplementar...   \n",
              "7    Item 8. Financial Statements and Supplementar...   \n",
              "8    Item 8. Financial Statements and Supplementar...   \n",
              "9    Item 8. Financial Statements and Supplementar...   \n",
              "10   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "11   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "12   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "13   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "14   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "15   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "16   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "17   ITEM 8. FINANCIAL STATE MENTS AND SUPPLEMENTA...   \n",
              "18   ITEM 8. FINANCIAL STATE MENTS AND SUPPLEMENTA...   \n",
              "19   Item 8Financial Statements and Supplementary ...   \n",
              "20   Item 8Financial Statements and Supplementary ...   \n",
              "21   Item 8Financial Statements and Supplementary ...   \n",
              "22   Item 8Financial Statements and Supplementary ...   \n",
              "23   Item 8Financial Statements and Supplementary ...   \n",
              "24   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "25   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "26   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "27   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "28   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "29   Item 8. Financial Statements and Supplementar...   \n",
              "30   Item 8. Financial Statements and Supplementar...   \n",
              "31   Item 8. Financial Statements and Supplementar...   \n",
              "32   Item 8. Financial Statements and Supplementar...   \n",
              "33   Item 8. Financial Statements and Supplementar...   \n",
              "34   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "35   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "36   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "37   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "38   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "39   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "40   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "41   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "42   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "43   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "44   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "45   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "46   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "47   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "48   ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...   \n",
              "\n",
              "                                                   9A  \n",
              "0    Item 9A. Controls and Procedures Evaluation o...  \n",
              "1    Item 9A. Controls and Procedures Evaluation o...  \n",
              "2    Item 9A. Controls and Procedures Evaluation o...  \n",
              "3    Item 9A. Controls and Procedures Evaluation o...  \n",
              "4    Item 9A. Controls and Procedures Evaluation o...  \n",
              "5    Item 9A. Controls and Procedures. Management ...  \n",
              "6    Item 9A. Controls and Procedures. Management ...  \n",
              "7    Item 9A. Controls and Procedures. Management ...  \n",
              "8    Item 9A. Controls and Procedures. Management ...  \n",
              "9    Item 9A. Controls and Procedures. Management ...  \n",
              "10   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "11   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "12   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "13   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "14   ITEM 9A. CONTROLS AND PROCEDURES Under the su...  \n",
              "15   ITEM 9A. CONTROLS AND PROCEDURES Under the su...  \n",
              "16   ITEM 9A. CONTROLS AND PROCEDURES Under the su...  \n",
              "17   ITEM 9A. CONTROLS AND PROCEDURES Under the su...  \n",
              "18   ITEM 9A. CONTROLS AND PROCEDURES Under the su...  \n",
              "19   Item 9AControls and Procedures Evaluation of ...  \n",
              "20   Item 9AControls and Procedures Evaluation of ...  \n",
              "21   Item 9AControls and Procedures Evaluation of ...  \n",
              "22   Item 9AControls and Procedures Evaluation of ...  \n",
              "23   Item 9AControls and Procedures Disclosure Con...  \n",
              "24   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "25   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "26   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "27   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "28   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "29   Item 9A. Controls and Procedures. (a) Disclos...  \n",
              "30   Item 9A. Controls and Procedures. (a) Disclos...  \n",
              "31   Item 9A. Controls and Procedures. (a) Disclos...  \n",
              "32   Item 9A. Controls and Procedures. (a) Disclos...  \n",
              "33   Item 9A. Controls and Procedures. (a) Disclos...  \n",
              "34   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "35   ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...  \n",
              "36   ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...  \n",
              "37   ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...  \n",
              "38   ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...  \n",
              "39   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "40   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "41   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "42   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "43   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "44   Item 9A. Controls and procedures Evaluation o...  \n",
              "45   Item 9A. Controls and procedures Evaluation o...  \n",
              "46   Item 9A. Controls and procedures Evaluation o...  \n",
              "47   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  \n",
              "48   ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-83ee10c3-c55b-4414-8f82-41a96e121469\">\n",
              "    <div class=\"colab-df-container\">\n",
              "      <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Company</th>\n",
              "      <th>Reporting_Date</th>\n",
              "      <th>1</th>\n",
              "      <th>1A</th>\n",
              "      <th>1B</th>\n",
              "      <th>2</th>\n",
              "      <th>3</th>\n",
              "      <th>5</th>\n",
              "      <th>7</th>\n",
              "      <th>7A</th>\n",
              "      <th>8</th>\n",
              "      <th>9A</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Meta</td>\n",
              "      <td>2021</td>\n",
              "      <td>Item 1. Business Overview Our mission is to g...</td>\n",
              "      <td>Item 1A. Risk Factors Certain factors may hav...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments None.</td>\n",
              "      <td>Item 2. Properties Our corporate headquarters...</td>\n",
              "      <td>Item 3. Legal Proceedings Beginning on March ...</td>\n",
              "      <td>Item 5. Market for Registrant's Common Equity...</td>\n",
              "      <td>Item 7. Management's Discussion and Analysis ...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Meta</td>\n",
              "      <td>2020</td>\n",
              "      <td>Item 1. Business Overview Our mission is to g...</td>\n",
              "      <td>Item 1A. Risk Factors Certain factors may hav...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments None.</td>\n",
              "      <td>Item 2. Properties  Our corporate headquarter...</td>\n",
              "      <td>Item 3. Legal Proceedings Beginning on March ...</td>\n",
              "      <td>Item 5. Market for Registrant's Common Equity...</td>\n",
              "      <td>Item 7. Management's Discussion and Analysis ...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>Meta</td>\n",
              "      <td>2019</td>\n",
              "      <td>Item 1. Business Overview Our mission is to g...</td>\n",
              "      <td>Item 1A. Risk Factors Certain factors may hav...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments None.</td>\n",
              "      <td>Item 2. Properties  Our corporate headquarter...</td>\n",
              "      <td>Item 3. Legal Proceedings Beginning on March ...</td>\n",
              "      <td>Item 5. Market for Registrant's Common Equity...</td>\n",
              "      <td>Item 7. Management's Discussion and Analysis ...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Meta</td>\n",
              "      <td>2018</td>\n",
              "      <td>Item 1. Business Overview Our mission is to g...</td>\n",
              "      <td>Item 1A. Risk Factors Certain factors may hav...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments None.</td>\n",
              "      <td>Item 2. Properties  Our corporate headquarter...</td>\n",
              "      <td>Item 3. Legal Proceedings Beginning on March ...</td>\n",
              "      <td>Item 5. Market for Registrant's Common Equity...</td>\n",
              "      <td>Item 7. Management's Discussion and Analysis ...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>Meta</td>\n",
              "      <td>2017</td>\n",
              "      <td>Item 1. Business Overview Our mission is to g...</td>\n",
              "      <td>Item 1A. Risk Factors Certain factors may hav...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments None.</td>\n",
              "      <td>Item 2. Properties  Our corporate headquarter...</td>\n",
              "      <td>Item 3. Legal Proceedings Beginning on May 22...</td>\n",
              "      <td>Item 5. Market for Registrant's Common Equity...</td>\n",
              "      <td>Item 7. Management's Discussion and Analysis ...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Merck &amp; Co.</td>\n",
              "      <td>2021</td>\n",
              "      <td>Item 1. Business. Merck  Co., Inc. (Merck or ...</td>\n",
              "      <td>Item 1A. Risk Factors. Summary Risk Factors T...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. None.</td>\n",
              "      <td>Item 2. Properties. The Companys corporate he...</td>\n",
              "      <td>Item 3. Legal Proceedings. The information ca...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. Management ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>Merck &amp; Co.</td>\n",
              "      <td>2020</td>\n",
              "      <td>Item 1. Business. Merck  Co., Inc. (Merck or ...</td>\n",
              "      <td>Item 1A. Risk Factors. Summary Risk Factors T...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. None.</td>\n",
              "      <td>Item 2. Properties. The Companys corporate he...</td>\n",
              "      <td>Item 3. Legal Proceedings. The information ca...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. Management ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>7</th>\n",
              "      <td>Merck &amp; Co.</td>\n",
              "      <td>2019</td>\n",
              "      <td>Item 1. Business. Merck  Co., Inc. (Merck or ...</td>\n",
              "      <td>Item 1A. Risk Factors. Investors should caref...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. None.</td>\n",
              "      <td>Item 2. Properties. The Companys corporate he...</td>\n",
              "      <td>Item 3. Legal Proceedings. The information ca...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. Management ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>8</th>\n",
              "      <td>Merck &amp; Co.</td>\n",
              "      <td>2018</td>\n",
              "      <td>Item 1. Business. Merck  Co., Inc. (Merck or ...</td>\n",
              "      <td>Item 1A. Risk Factors. Investors should caref...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. None.</td>\n",
              "      <td>Item 2. Properties. The Companys corporate he...</td>\n",
              "      <td>Item 3. Legal Proceedings. The information ca...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. Management ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>9</th>\n",
              "      <td>Merck &amp; Co.</td>\n",
              "      <td>2017</td>\n",
              "      <td>Item 1. Business. Merck  Co., Inc. (Merck or ...</td>\n",
              "      <td>Item 1A. Risk Factors. Investors should caref...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. None.</td>\n",
              "      <td>Item 2. Properties. The Companys corporate he...</td>\n",
              "      <td>Item 3. Legal Proceedings. The information ca...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. Management ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>10</th>\n",
              "      <td>Alphabet Inc.</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESS Overview As our founders Lar...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Our operations and fina...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our headquarters are locat...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS For a description o...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>11</th>\n",
              "      <td>Alphabet Inc.</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESS Overview As our founders Lar...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Our operations and fina...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our headquarters are locat...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS For a description o...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>12</th>\n",
              "      <td>Alphabet Inc.</td>\n",
              "      <td>2019</td>\n",
              "      <td>ITEM 1. BUSINESS Overview As our founders Lar...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Our operations and fina...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our headquarters are locat...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS For a description o...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>13</th>\n",
              "      <td>Alphabet Inc.</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1. BUSINESS Overview As our founders Lar...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Our operations and fina...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our headquarters are locat...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS For a description o...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>14</th>\n",
              "      <td>Microsoft Corporation</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESSGENERAL Embracing Our FutureM...</td>\n",
              "      <td>ITEM 1A. RISK FACTORSOur operations and finan...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS We have re...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our corporate headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Refer to Note 15  C...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Under the su...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>15</th>\n",
              "      <td>Microsoft Corporation</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESSGENERAL Embracing Our FutureM...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Our operations and fina...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS We have re...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our corporate headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS While not material ...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Under the su...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>16</th>\n",
              "      <td>Microsoft Corporation</td>\n",
              "      <td>2019</td>\n",
              "      <td>ITEM 1. BUSINESS GENERAL Embracing Our Future...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Our operations and fina...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS We have re...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our corporate headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS While not material ...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Under the su...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>17</th>\n",
              "      <td>Microsoft Corporation</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1. BUSINESS GENERAL Embracing Our Future...</td>\n",
              "      <td>ITEM 1A. RIS K FACTORS Our operations and fin...</td>\n",
              "      <td>ITEM 1B. UNRESOLVE D STAFF COMMENTS We have r...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our corporate headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS While not material ...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATE MENTS AND SUPPLEMENTA...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Under the su...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>18</th>\n",
              "      <td>Microsoft Corporation</td>\n",
              "      <td>2017</td>\n",
              "      <td>ITEM 1. BUSINESS GENERAL Embracing Our Future...</td>\n",
              "      <td>ITEM 1A. RIS K FACTORS Our operations and fin...</td>\n",
              "      <td>ITEM 1B. UNRESOLVE D STAFF COMMENTS We have r...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our corporate headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS While not material ...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITAT IVE DISCLO...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATE MENTS AND SUPPLEMENTA...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Under the su...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>19</th>\n",
              "      <td>Costco</td>\n",
              "      <td>2021</td>\n",
              "      <td>Item 1Business Costco Wholesale Corporation a...</td>\n",
              "      <td>Item 1ARisk Factors The risks described below...</td>\n",
              "      <td>Item 1BUnresolved Staff Comments None.</td>\n",
              "      <td>Item 2Properties Warehouse Properties At Augu...</td>\n",
              "      <td>Item 3Legal Proceedings See discussion of Leg...</td>\n",
              "      <td>Item 5Market for Registrants Common Equity, R...</td>\n",
              "      <td>Item 7Management's Discussion and Analysis of...</td>\n",
              "      <td>Item 7AQuantitative and Qualitative Disclosur...</td>\n",
              "      <td>Item 8Financial Statements and Supplementary ...</td>\n",
              "      <td>Item 9AControls and Procedures Evaluation of ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>20</th>\n",
              "      <td>Costco</td>\n",
              "      <td>2020</td>\n",
              "      <td>Item 1Business Costco Wholesale Corporation a...</td>\n",
              "      <td>Item 1ARisk Factors The risks described below...</td>\n",
              "      <td>Item 1BUnresolved Staff Comments None.</td>\n",
              "      <td>Item 2Properties Warehouse Properties At Augu...</td>\n",
              "      <td>Item 3Legal Proceedings See discussion of Leg...</td>\n",
              "      <td>Item 5Market for Registrants Common Equity, R...</td>\n",
              "      <td>Item 7Management's Discussion and Analysis of...</td>\n",
              "      <td>Item 7AQuantitative and Qualitative Disclosur...</td>\n",
              "      <td>Item 8Financial Statements and Supplementary ...</td>\n",
              "      <td>Item 9AControls and Procedures Evaluation of ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>21</th>\n",
              "      <td>Costco</td>\n",
              "      <td>2019</td>\n",
              "      <td>Item 1Business Costco Wholesale Corporation a...</td>\n",
              "      <td>Item 1ARisk Factors The risks described below...</td>\n",
              "      <td>Item 1BUnresolved Staff Comments None.</td>\n",
              "      <td>Item 2Properties Warehouse Properties At Sept...</td>\n",
              "      <td>Item 3Legal Proceedings See discussion of Leg...</td>\n",
              "      <td>Item 5Market for Registrants Common Equity, R...</td>\n",
              "      <td>Item 7Management's Discussion and Analysis of...</td>\n",
              "      <td>Item 7AQuantitative and Qualitative Disclosur...</td>\n",
              "      <td>Item 8Financial Statements and Supplementary ...</td>\n",
              "      <td>Item 9AControls and Procedures Evaluation of ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>22</th>\n",
              "      <td>Costco</td>\n",
              "      <td>2018</td>\n",
              "      <td>Item 1Business Costco Wholesale Corporation a...</td>\n",
              "      <td>Item 1ARisk Factors The risks described below...</td>\n",
              "      <td>Item 1BUnresolved Staff Comments None.</td>\n",
              "      <td>Item 2Properties Warehouse Properties At Sept...</td>\n",
              "      <td>Item 3Legal Proceedings See discussion of Leg...</td>\n",
              "      <td>Item 5Market for Registrants Common Equity, R...</td>\n",
              "      <td>Item 7Management's Discussion and Analysis of...</td>\n",
              "      <td>Item 7AQuantitative and Qualitative Disclosur...</td>\n",
              "      <td>Item 8Financial Statements and Supplementary ...</td>\n",
              "      <td>Item 9AControls and Procedures Evaluation of ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>23</th>\n",
              "      <td>Costco</td>\n",
              "      <td>2017</td>\n",
              "      <td>Item 1Business Costco Wholesale Corporation a...</td>\n",
              "      <td>Item 1ARisk Factors The risks described below...</td>\n",
              "      <td>Item 1BUnresolved Staff Comments None.</td>\n",
              "      <td>Item 2Properties Warehouse Properties At Sept...</td>\n",
              "      <td>Item 3Legal Proceedings See discussion of Leg...</td>\n",
              "      <td>Item 5Market for Registrants Common Equity, R...</td>\n",
              "      <td>Item 7Managements Discussion and Analysis of ...</td>\n",
              "      <td>Item 7AQuantitative and Qualitative Disclosur...</td>\n",
              "      <td>Item 8Financial Statements and Supplementary ...</td>\n",
              "      <td>Item 9AControls and Procedures Disclosure Con...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>24</th>\n",
              "      <td>Pfizer</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESS ABOUT PFIZER Pfizer Inc. is ...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS This section describes ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS N/A ITEM 2...</td>\n",
              "      <td>ITEM 2. PROPERTIES We own and lease space glo...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Certain legal proce...</td>\n",
              "      <td>ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>25</th>\n",
              "      <td>Pfizer</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESS ABOUT PFIZER Pfizer Inc. is ...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS This section describes ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS N/A ITEM 2...</td>\n",
              "      <td>ITEM 2. PROPERTIES We own and lease space aro...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Certain legal proce...</td>\n",
              "      <td>ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>26</th>\n",
              "      <td>Pfizer</td>\n",
              "      <td>2019</td>\n",
              "      <td>Item 1. BusinessAbout Pfizer section in this ...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS The statements in this ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES As of December 31, 2019 , ...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Certain legal proce...</td>\n",
              "      <td>ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>27</th>\n",
              "      <td>Pfizer</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1. BUSINESS ABOUT PFIZER Pfizer Inc. is ...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS The statements in this ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES In 2017 , we continued to ...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Certain legal proce...</td>\n",
              "      <td>ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>28</th>\n",
              "      <td>Pfizer</td>\n",
              "      <td>2017</td>\n",
              "      <td>ITEM 1. BUSINESS GENERAL Pfizer Inc. is a res...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS The statements in this ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES In 2016, we continued to c...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Certain legal proce...</td>\n",
              "      <td>ITEM 5. MARKET FOR THE COMPANYS COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>29</th>\n",
              "      <td>PepsiCo</td>\n",
              "      <td>2021</td>\n",
              "      <td>Item 1. Business. When used in this report, t...</td>\n",
              "      <td>Item 1A. Risk Factors. The following risks, s...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. We have r...</td>\n",
              "      <td>Item 2. Properties. Our principal executive o...</td>\n",
              "      <td>Item 3. Legal Proceedings. We and our subsidi...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. (a) Disclos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>30</th>\n",
              "      <td>PepsiCo</td>\n",
              "      <td>2020</td>\n",
              "      <td>Item 1. Business. When used in this report, t...</td>\n",
              "      <td>Item 1A. Risk Factors. The following risks, s...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. We have r...</td>\n",
              "      <td>Item 2. Properties. Our principal executive o...</td>\n",
              "      <td>Item 3. Legal Proceedings. We and our subsidi...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. (a) Disclos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>31</th>\n",
              "      <td>PepsiCo</td>\n",
              "      <td>2019</td>\n",
              "      <td>Item 1. Business. When used in this report, t...</td>\n",
              "      <td>Item 1A. Risk Factors. You should carefully c...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. We have r...</td>\n",
              "      <td>Item 2. Properties. Our principal executive o...</td>\n",
              "      <td>Item 3. Legal Proceedings. We and our subsidi...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. (a) Disclos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>32</th>\n",
              "      <td>PepsiCo</td>\n",
              "      <td>2018</td>\n",
              "      <td>Item 1. Business. When used in this report, t...</td>\n",
              "      <td>Item 1A. Risk Factors. You should carefully c...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. We have r...</td>\n",
              "      <td>Item 2. Properties. Our principal executive o...</td>\n",
              "      <td>Item 3. Legal Proceedings. As previously disc...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. (a) Disclos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>33</th>\n",
              "      <td>PepsiCo</td>\n",
              "      <td>2017</td>\n",
              "      <td>Item 1. Business. When used in this report, t...</td>\n",
              "      <td>Item 1A. Risk Factors. You should carefully c...</td>\n",
              "      <td>Item 1B. Unresolved Staff Comments. We have r...</td>\n",
              "      <td>Item 2. Properties. Our principal executive o...</td>\n",
              "      <td>Item 3. Legal Proceedings. As previously disc...</td>\n",
              "      <td>Item 5. Market for Registrants Common Equity,...</td>\n",
              "      <td>Item 7. Managements Discussion and Analysis o...</td>\n",
              "      <td>Item 7A. Quantitative and Qualitative Disclos...</td>\n",
              "      <td>Item 8. Financial Statements and Supplementar...</td>\n",
              "      <td>Item 9A. Controls and Procedures. (a) Disclos...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>34</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESS Overview AbbVie (1) is a glo...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS You should carefully co...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS None.</td>\n",
              "      <td>ITEM 2. PROPERTIES AbbVie's corporate offices...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Information pertain...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>35</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESS Overview AbbVie (1) is a glo...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS You should carefully co...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS None.</td>\n",
              "      <td>ITEM 2. PROPERTIES AbbVie's corporate offices...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Information pertain...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Disclosure C...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>36</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2019</td>\n",
              "      <td>ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS  You should carefully c...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS  None.</td>\n",
              "      <td>ITEM 2. PROPERTIES  AbbVie's corporate office...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS  Information pertai...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>37</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS   You should carefully ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS  None.</td>\n",
              "      <td>ITEM 2. PROPERTIES  AbbVie's corporate office...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS  Information pertai...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>38</th>\n",
              "      <td>AbbVie</td>\n",
              "      <td>2017</td>\n",
              "      <td>ITEM 1. BUSINESS  Overview AbbVie (1) is a gl...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS   You should carefully ...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS  None.</td>\n",
              "      <td>ITEM 2. PROPERTIES  AbbVie's corporate office...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS  Information pertai...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES  Disclosure ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>39</th>\n",
              "      <td>Coca-Cola</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESS In this report, the terms Th...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS In addition to the othe...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our worldwide headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS The Company is invo...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>40</th>\n",
              "      <td>Coca-Cola</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESS In this report, the terms \"T...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS In addition to the othe...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our worldwide headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS The Company is invo...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>41</th>\n",
              "      <td>Coca-Cola</td>\n",
              "      <td>2019</td>\n",
              "      <td>ITEM 1. BUSINESS In this report, the terms \"T...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS In addition to the othe...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our worldwide headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS The Company is invo...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>42</th>\n",
              "      <td>Coca-Cola</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1. BUSINESS In this report, the terms \"T...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS In addition to the othe...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our worldwide headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS The Company is invo...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>43</th>\n",
              "      <td>Coca-Cola</td>\n",
              "      <td>2017</td>\n",
              "      <td>ITEM 1. BUSINESS In this report, the terms \"T...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS In addition to the othe...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES Our worldwide headquarters...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS The Company is invo...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS ...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>44</th>\n",
              "      <td>Mastercard</td>\n",
              "      <td>2021</td>\n",
              "      <td>ITEM 1. BUSINESS Item 1. Business Overview Ma...</td>\n",
              "      <td>Item 1A. Risk factors RISK HIGHLIGHTS Legal a...</td>\n",
              "      <td>Item 1B. Unresolved staff comments Not applic...</td>\n",
              "      <td>Item 2. Properties We own our corporate headq...</td>\n",
              "      <td>Item 3. Legal proceedings Refer to Note 13 (A...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOS...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>Item 9A. Controls and procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>45</th>\n",
              "      <td>Mastercard</td>\n",
              "      <td>2020</td>\n",
              "      <td>ITEM 1. BUSINESS Item 1. Business Overview Ma...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Item 1A. Risk factors R...</td>\n",
              "      <td>Item 1B. Unresolved staff comments Not applic...</td>\n",
              "      <td>Item 2. Properties We own our corporate headq...</td>\n",
              "      <td>Item 3. Legal proceedings Refer to Note 13 (A...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>Item 7A. Quantitative and qualitative disclos...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>Item 9A. Controls and procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>46</th>\n",
              "      <td>Mastercard</td>\n",
              "      <td>2019</td>\n",
              "      <td>Item 1. Business</td>\n",
              "      <td>Item 1A. Risk factors</td>\n",
              "      <td>Item 1B. Unresolved staff comments</td>\n",
              "      <td>Item 2. Properties</td>\n",
              "      <td>Item 3. Legal proceedings</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>Item 7A. Quantitative and qualitative disclos...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>Item 9A. Controls and procedures Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>47</th>\n",
              "      <td>Mastercard</td>\n",
              "      <td>2018</td>\n",
              "      <td>ITEM 1.  BUSINESS Overview Mastercard is a te...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Legal and Regulatory Pa...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES As of December 31, 2018 , ...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Refer to Note 12 (A...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLO...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>48</th>\n",
              "      <td>Mastercard</td>\n",
              "      <td>2017</td>\n",
              "      <td>ITEM 1.  BUSINESS Overview Mastercard is a te...</td>\n",
              "      <td>ITEM 1A. RISK FACTORS Legal and Regulatory Di...</td>\n",
              "      <td>ITEM 1B. UNRESOLVED STAFF COMMENTS Not applic...</td>\n",
              "      <td>ITEM 2. PROPERTIES As of December 31, 2017 , ...</td>\n",
              "      <td>ITEM 3. LEGAL PROCEEDINGS Refer to Notes 10 (...</td>\n",
              "      <td>ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY,...</td>\n",
              "      <td>ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS O...</td>\n",
              "      <td>ITEM 7A.  QUANTITATIVE AND QUALITATIVE DISCLO...</td>\n",
              "      <td>ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAR...</td>\n",
              "      <td>ITEM 9A. CONTROLS AND PROCEDURES Evaluation o...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "      <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-83ee10c3-c55b-4414-8f82-41a96e121469')\"\n",
              "              title=\"Convert this dataframe to an interactive table.\"\n",
              "              style=\"display:none;\">\n",
              "        \n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M0 0h24v24H0V0z\" fill=\"none\"/>\n",
              "    <path d=\"M18.56 5.44l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94zm-11 1L8.5 8.5l.94-2.06 2.06-.94-2.06-.94L8.5 2.5l-.94 2.06-2.06.94zm10 10l.94 2.06.94-2.06 2.06-.94-2.06-.94-.94-2.06-.94 2.06-2.06.94z\"/><path d=\"M17.41 7.96l-1.37-1.37c-.4-.4-.92-.59-1.43-.59-.52 0-1.04.2-1.43.59L10.3 9.45l-7.72 7.72c-.78.78-.78 2.05 0 2.83L4 21.41c.39.39.9.59 1.41.59.51 0 1.02-.2 1.41-.59l7.78-7.78 2.81-2.81c.8-.78.8-2.07 0-2.86zM5.41 20L4 18.59l7.72-7.72 1.47 1.35L5.41 20z\"/>\n",
              "  </svg>\n",
              "      </button>\n",
              "      \n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      flex-wrap:wrap;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "      <script>\n",
              "        const buttonEl =\n",
              "          document.querySelector('#df-83ee10c3-c55b-4414-8f82-41a96e121469 button.colab-df-convert');\n",
              "        buttonEl.style.display =\n",
              "          google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "        async function convertToInteractive(key) {\n",
              "          const element = document.querySelector('#df-83ee10c3-c55b-4414-8f82-41a96e121469');\n",
              "          const dataTable =\n",
              "            await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                     [key], {});\n",
              "          if (!dataTable) return;\n",
              "\n",
              "          const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "            '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "            + ' to learn more about interactive tables.';\n",
              "          element.innerHTML = '';\n",
              "          dataTable['output_type'] = 'display_data';\n",
              "          await google.colab.output.renderOutput(dataTable, element);\n",
              "          const docLink = document.createElement('div');\n",
              "          docLink.innerHTML = docLinkHtml;\n",
              "          element.appendChild(docLink);\n",
              "        }\n",
              "      </script>\n",
              "    </div>\n",
              "  </div>\n",
              "  "
            ]
          },
          "metadata": {},
          "execution_count": 11
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "final_combined_dataset.to_csv('./datasets/final_combined_dataset.csv')"
      ],
      "metadata": {
        "id": "qVfded4VJ9X8"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}